• edge
  • Stacks Image 69472
  • Stacks Image 69474
  • Stacks Image 69476
  • Stacks Image 69478

COVID-19 and APMG

Stacks Image 69806

This is a critical time for pathology. The COVID-19 pandemic presents a tremendous challenge to laboratories, laboratory personnel, and the pathologists who are on the front lines. Affiliated Pathologists Medical Group, with it 15 hospitals and healthcare facilities has experienced the same issues with testing, staffing challenges, workload revisions, and working remotely. We continue to support our community members who are personally medically, financially affected by the crisis.

Please click
HERE to read some of our stories.


Oregon Pathologists Association Hosts Scott Binder, MD on August 29th

Stacks Image 69837

Dr. Binder will be giving a virtual dermatopathology seminar, hosted by the Oregon Pathologists Association. The date is August 29th from 9am-Noon Pacific Time. Two main topics will be discussed:
  • Nevoid Melanomas
  • Primary cutaneous adnexal tumors versus visceral Mets from unknown primaries

More details can be found HERE.


Scott Binder, MD Speaks at CAP's Virtual Lecture Series for Pathology Residents

Stacks Image 69824

To help resident members get high-quality education-based content during this unique and challenging time, the College of American Pathologists is offering a virtual lecture series during the month of April. These lectures are delivered by experts from across the United States and cover a broad spectrum of anatomic pathology and clinical pathology topics. APMG pathologist Scott Binder, MD is lecturing April 14th. The topic is Solar Melanoma. More details on the program can be found HERE.


Changes to CLIA Licensing in the Time of COVID-19

Stacks Image 69814

The CAP and others have successfully lobbied the CMS to waive the requirement for a CLIA-license to sign out cases remotely provided that the designated primary site does have a CLIA certificate. The waiver also includes review of clinical pathology images and data (e.g.,electropherograms, gel images, fluorescence in situ hybridization, molecular results, flow cytometry dot plots, blood bank and HLA data).

This waiver is important because it will preserve the continuity of patient care, ensure ongoing quality by getting cases to the appropriate pathologists where subspecialty review is required, and will optimize the safety of pathologists by minimizing their exposure to busy hospitals with a concentration of patients, specimens and surfaces harboring SARS-CoV-2.

There have been many questions about the impact of this waiver and what remote sign-out actually entails.

In response, the Digital and Computational Pathology Committee and the Informatics committee of the CAP has created a set of Frequently Asked Questions. This effort was led by Andy Evans, MD who chairs the Digital and Computational Pathology Committee and APMG pathologist Eric Glassy, MD who chairs the Information Technology Leadership Committee of the CAP.

Please click HERE to go to the CAP FAQ page about remote sign-out.


James Harris, MD, APMG President, Discusses the Importance of Advocacy.

The College of American Pathologists interviewed Dr. Harris about protecting the future of pathology by supprting advocacy and how being first and being involved are his keys to success. Click the image to view the video.

Stacks Image 69768


APMG at USCAP 2020

Affiliated Pathologists Medical Group was well represented at the USCAP meeting in Los Angeles. Eric F. Glassy, MD presented two talks. The first was part of the CAP Residents Forum, entitled Blue Pill or Red Pill? Artificial intelligence & You. The second was part of the CAP Companion Society meeting entitled Fear & Loathing in Pathology: The Disruptive Force of Digitalization.

Stacks Image 69784
Stacks Image 69791


ADVANCE 8.0

Stacks Image 69618
Stacks Image 69630
Stacks Image 69638
Stacks Image 69624
Stacks Image 69642
Stacks Image 69622

Affiliated Pathologists Medical Group embarked on a Strategic Planning effort in 2011 which culminated in a full day seminar called Advance 1.0. (The program was similar to a retreat but we preferred to call it an Advance). APMG’s Strategic Plan assessed and defined the mission, vision, and goals that will drive APMG’s work and partnerships for the foreseeable future. We felt that by planning now and focusing our resources for the coming years, APMG would be able to respond to the rapid health care reform changes that are occurring in our environment, economy, and society. The program was successful and is now a yearly event. Our 8th Advance was held in July, 2018.

This years presenters and topics:
  • Suchetha Adiga, MD – HPV- Truths and Trivia
  • Nicholas Harding Jackson, MD – Common diagnostic dilemmas in GU pathology
  • Michelle Fajardo, DO – Breast Cancer: Changes In the AJCC Cancer Staging Manual, 8th Edition
  • James Harris, MD – CAP Advocacy/PathPAC/Leadership
  • Jeffrey Virgin, MD – Two Colon Polyposis Cases with Subtle Findings
  • Georgia Tunstill, MD – HER2 Testing in Breast Cancer; 2018 Guidelines
  • Eric Glassy, MD – The Future of Pathology is Artificial

A special thank you to those Physicians and Staff who helped with the planning, prizes and breakout sessions: Sharon VanWaardenburg, Stanette Kennebrew, JD, MBA and Drs. Rashidi, Peake, Duffy, Dellamaggiora and De Vito.



APMG's New President: James Harris, MD

Stacks Image 69661
Stacks Image 69653
Stacks Image 69655

James Harris, MD is the new APMG president, directing the board of 7 pathologists, 18 shareholders and 40 pathologist members. He is medical director at Good Samaritan Hospital in Los Angeles and APMG Lab and also chariman of the APMG Recruitment Committee. He has extensive experience in flow cytometry, including technical only flow, immunohistochemistry and image analysis. Dr. Harris is also on the board of the California Society of Pathologists and was also recently elected to the CAP House of Delegates.

You can read more about Dr. Harris here.




APMG Storms Capital Hill

Stacks Image 69679
Stacks Image 69687
Stacks Image 69689
Legend: CAP Pathologists gather on the capital steps for a photo op. Drs. Harris and Glassy are in the middle, second row from back. Panel discussion at the CAP Policy meeting. California Delegates Mike Dugan, Robert Freedman, and James Harris meet in Diane Feinstein's office.

APMG's pathologists James Harris, MD and Eric F. Glassy, MD attended the CAP Advocacy Meeting in Washington DC last April. They had a chance to engage senators and representatives to advocate for a CAP-sponsored bill to improve the local carrier determination process. You can read a summary of the meeting here and enroll in next year's Advocacy Meeting here.

CONNECT WITH US
FOLLOW APMG

          




Renowned Dermatopathologist, Dr. Scott Binder, joins APMG

edge

Dr. Binder is a nationally and internationally known dermatopathologist with one of the largest consultative practices in the country.  He receives more than 6,000 second opinion consults on difficult and challenging cases in dermatopathology from academic institutions, reference laboratories and community pathology groups from all over the country as well as international cases from Greece, China, and Korea. Dr. Binder was inducted into the Chinese Academy of Medical Sciences in 2006.

Dr. Binder began his academic career as an Associate Clinical Professor at USC/LA County Medical Center, and was recruited by Cedars-Sinai as Director of Surgical Pathology and Head of Dermatopathology and Gastrointestinal Pathology. In 2001, Dr. Binder joined the Department of Pathology and Laboratory Medicine at UCLA where he was Professor of Clinical Pathology and Professor of Dermatology. In 2006, Dr. Binder was appointed as Senior Vice Chair of the Department and Director of Clinical Pathology Services; in 2007, he was chosen as the Pritzker Family Chair of Clinical Pathology and Dermatology. In 2002, Dr. Binder founded the Dermatopathology Fellowship Program at UCLA and trained fellows for 15 years who hold both academic and community-based positions across the US. He has trained international scholars from countries including China, Germany, Greece, Iran, Israel, Japan, and South Korea among others.

APMG is pleased to welcome Dr. Binder to our pathology group.



Olympia Medical Center is the Newest Hospital to Partner with APMG


edge

edge

Olympia Medical Center in a 204 bed acute care hospital serving the Los Angeles mid-Wilshire and metropolitan geographic population. The hospital is recognized for outstanding delivery of care in geriatric medicine, spine surgery, orthopedics, ophthalmology, minimally invasive surgery, and emergency care. It is a center of excellence for the Barnet Continent Intestinal Reservoir (BCIR) procedure. Sanja Krajisnik, MD is the pathology director.